Data Foundry

Medical device recalls 2014

BD BBL Vancomycin Screen Agar Catalog number 222204 Vancomycin Screen… — Class II medical device recall Z-2628-2014

Terminated recall by Becton Dickinson & Co., reported 2014-09-24, distributed nationwide. These lots of Agar may have exhibited breakthrough growth of vancomycin susceptible Enterococcus species contr

Recall numberZ-2628-2014
Product typeMedical device
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmBecton Dickinson & Co., Sparks, MD, United States
Recall initiated2014-07-28
Classified2014-09-12
Reported by FDA2014-09-24
Terminated2016-01-07
DistributedNationwide (US)
Countries outside the USBE, CA, CO, IN, MX, SG, TW
Quantity28,540
Lot numbers4042217, 4048040, 4052349, 4058242, 4073274, 4080291, 4127728
Model numbers222204

Product

BD BBL Vancomycin Screen Agar Catalog number 222204 Vancomycin Screen Agar is used to test enterococci for resistance to vancomycin and to predict the synergistic activity of this antimicrobial with an aminoglycoside antimicrobial.

Reason for recall

These lots of Agar may have exhibited breakthrough growth of vancomycin susceptible Enterococcus species control organisms. Agar that allows susceptible enterococci to grow appears as a falsely resistant culture. If a lab does not QC, the error would be identified as falsely resistant enterococci would have further AST workup. There could be a delay in the identification of false-resistance

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-2628-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.